|
Volumn 324, Issue 5928, 2009, Pages 815-817
|
Molecular diagnostics: Personalizing personalized medicine
a
a
Pocatello
*
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
CETUXIMAB;
CHOLESTEROL;
CYTOSINE;
DNA;
ERLOTINIB;
GEFITINIB;
GLUCOSE;
LOCKED NUCLEIC ACID;
MESSENGER RNA;
MICRORNA;
NUCLEIC ACID;
PANITUMUMAB;
PEMETREXED;
PROSTATE SPECIFIC ANTIGEN;
RIFAMPICIN;
VIMENTIN;
MEDICINE;
MOLECULAR ANALYSIS;
ASSAY;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER HORMONE THERAPY;
CANCER RISK;
CANCER SCREENING;
CHOLESTEROL BLOOD LEVEL;
CLINICAL LABORATORY;
COLORECTAL CANCER;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC TEST;
DIFFERENTIAL DIAGNOSIS;
DNA METHYLATION;
DRUG CHOICE;
GENE EXPRESSION;
GENE MUTATION;
GENETIC SCREENING;
GENOME;
HEART DISEASE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
ISOTOPE LABELING;
LABORATORY TEST;
LUNG NON SMALL CELL CANCER;
MASS SPECTROMETRY;
MEDICAL DECISION MAKING;
MEDICAL TECHNOLOGY;
MICROARRAY ANALYSIS;
MOLECULAR BIOLOGY;
MOLECULAR DIAGNOSTICS;
NEUROIMAGING;
NONHUMAN;
ONCOGENE;
ONCOGENE K RAS;
OVARY CANCER;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROSTATE CANCER;
PROSTATECTOMY;
REAL TIME POLYMERASE CHAIN REACTION;
SHORT SURVEY;
SINGLE NUCLEOTIDE POLYMORPHISM;
TREATMENT OUTCOME;
TUBERCULOSIS;
VIRUS LOAD;
|
EID: 66249116304
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.324_815 Document Type: Short Survey |
Times cited : (3)
|
References (0)
|